---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-000851"
form_type: "8-K"
ticker: "SRTS"
cik: "0001494891"
company_name: "Sensus Healthcare, Inc."
filed_at: "2025-05-15T23:59:59+00:00"
generated_at: "2026-05-21T04:51:18.606886+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sensus Healthcare Q1 revenues $8.3M, net loss $2.6M vs. net income $2.3M year ago; forecasts profitability rest of year

## Summary
- Revenue $8.3M, down 22% YoY from $10.7M; net loss $0.16 per share vs. net income $0.14 per diluted share.
- Gross margin 53.0% vs. 62.6% year ago due to lower sales and higher service costs.
- Shipped 21 SRT systems, including 15 to a large customer; treatment volume from FDAs increased 65% sequentially.
- Management expects profitability in each of next three quarters and full year; affirms 3-5 additional multisite FDA customers this year.
- R&D expense $2.6M vs. $0.9M driven by lobbying costs for billing code reimbursement.

## SEC filing metadata
- accession: 0001753926-25-000851
- form_type: 8-K
- ticker: SRTS
- cik: 0001494891
- company_name: Sensus Healthcare, Inc.
- filed_at: 2025-05-15T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1494891/000175392625000851/0001753926-25-000851-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1494891/000175392625000851/g084817_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-000851
- JSON: https://secwatch.observer/filing/0001753926-25-000851.json
- Plain text: https://secwatch.observer/filing/0001753926-25-000851.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.